<DOC>
	<DOCNO>NCT02819934</DOCNO>
	<brief_summary>A Phase I Study Investigate Absorption , Metabolism , Excretion KD101 Male Subjects</brief_summary>
	<brief_title>A Phase I Study Investigate ADME KD101</brief_title>
	<detailed_description />
	<criteria>Are able provide write informed consent The subject healthy Korean age 20 55 year , inclusive . The subject weigh least 55 body mass index ( BMI ) 27 Subjects evidence history clinically significant pulmonary , cardiovascular , hepatic , endocrine , hematological , neurologic psychiatric disease . Subjects evidence gastrointestinal disease affect absorption drug . Subjects history drug abuse positive result urine drug screen drug abuse Subjects take prescribed medicine herbal medicine within 2 week first administration investigational product , nonprescribed medicine vitamin supplement within 1 week prior first administration investigational product ( condition satisfy , subject may eligible trial judged investigator . ) Subjects donate unit whole blood within 30 day participate clinical trial within 60 day prior first administration investigational product Subject history allergy . Subject continue proper contraception method study period . Subjects consume 21 unit alcohol per week ( 1 unit = 10 g pure alcohol ) unable abstain drinking PK/PD test period Subjects unable abstain smoking PK/PD test period Subjects unable abstain grapefruit caffeine contain food 1 day prior first administration investigational product Subjects judge eligible study review clinical laboratory result reason investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>